HCA Healthcare

HCA · New York Stock Exchange · Health Care

☆ Follow

Shareholder advocacy aimed at HCA Healthcare

Nothing recorded yet. That means no campaign in our database names this company, not that none exists.

What shareholders voted on

From HCA Healthcare’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.

2026

Item	Kind	Asked for by	Support	Outcome
The stockholder proposal regarding shareholders’ right to act by written consent as described in the Proxy Statement	Shareholder proposal		22%	Failed
The stockholder proposal regarding a report on healthcare consequences as described in the Proxy Statement	Shareholder proposal	Julie Mayfield	10.9%	Failed
Wayne J. Riley, M.D	Company proposal		95.3%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2026 proxy statement	Company proposal		93.5%	Passed
The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026	Auditor		91.9%	Passed
Election of John W. Chidsey, III	Director		99.1%	Passed
Election of Samuel N. Hazen	Director		99.1%	Passed
Election of William R. Frist	Director		98%	Passed
Election of Andrea B. Smith	Director		96.9%	Passed
Election of Michael W. Michelson	Director		96.6%	Passed
Election of Thomas F. Frist III	Director		95.9%	Passed
Election of Hugh F. Johnston	Director		91.9%	Passed
Election of Nancy-Ann DeParle	Director		88.6%	Passed

2025

Item	Kind	Support	Outcome
The stockholder proposal regarding lavish golden parachutes as described in the Proxy Statement	Shareholder proposal	29%	Failed
The stockholder proposal regarding a report on acquisition strategy as described in the Proxy Statement	Shareholder proposal	12%	Failed
The stockholder proposal regarding an amendment to the Patient Safety and Quality of Care Committee charter as described in the Proxy Statement	Shareholder proposal	9.7%	Failed
The First Amendment to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc	Company proposal	97%	Passed
Wayne J. Riley, M.D	Company proposal	95.1%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2025 proxy statement	Company proposal	93.6%	Passed
The amendment to the Company’s amended and restated certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law	Company proposal	89.6%	Passed
The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025	Auditor	91%	Passed
Election of Samuel N. Hazen	Director	98.7%	Passed
Election of William R. Frist	Director	98.3%	Passed
Election of Andrea B. Smith	Director	98.1%	Passed
Election of Michael W. Michelson	Director	96.4%	Passed
Election of Robert J. Dennis	Director	96.4%	Passed
Election of Thomas F. Frist III	Director	95.7%	Passed
Election of Hugh F. Johnston	Director	92.5%	Passed
Election of Nancy-Ann DeParle	Director	89%	Passed

2024

Item	Kind	Asked for by	Support	Outcome
The stockholder proposal regarding a report on patient feedback regarding quality of care as described in the Company’s 2024 proxy statement	Shareholder proposal	Michael Frerichs	15.4%	Failed
The stockholder proposal regarding a report on maternal health outcomes as described in the Company’s 2024 proxy statement	Shareholder proposal		8.5%	Failed
The stockholder proposal regarding a report on risk mitigation regarding state restrictions for emergency abortions as described in the Company’s 2024 proxy statement	Shareholder proposal	United Church Funds	8.2%	Failed
Wayne J. Riley, M.D	Company proposal		98%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2024 proxy statement	Company proposal		94.1%	Passed
The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024	Auditor		92.3%	Passed
Election of Samuel N. Hazen	Director		99.3%	Passed
Election of Andrea B. Smith	Director		99.1%	Passed
Election of Meg G. Crofton	Director		99.1%	Passed
Election of Michael W. Michelson	Director		99%	Passed
Election of William R. Frist	Director		99%	Passed
Election of Nancy-Ann DeParle	Director		97.9%	Passed
Election of Thomas F. Frist III	Director		96.9%	Passed
Election of Robert J. Dennis	Director		96.4%	Passed
Election of Hugh F. Johnston	Director		89.1%	Passed

2023

Item	Kind	Asked for by	Support	Outcome
The stockholder proposal regarding political spending disclosure as described in the Company’s 2023 proxy statement	Shareholder proposal	John Chevedden	23.5%	Failed
The stockholder proposal regarding an amendment to the Patient Safety and Quality of Care Committee charter as described in the Company’s 2023 proxy statement	Shareholder proposal	Michael Frerichs	18.9%	Failed
The HCA Healthcare, Inc	Company proposal		98.7%	Passed
Wayne J. Riley, M.D	Company proposal		97.8%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2023 proxy statement	Company proposal		95.5%	Passed
The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023	Auditor		93.2%	Passed
Election of Andrea B. Smith	Director		99.6%	Passed
Election of Samuel N. Hazen	Director		99.5%	Passed
Election of Meg G. Crofton	Director		99.4%	Passed
Election of Michael W. Michelson	Director		99.1%	Passed
Election of William R. Frist	Director		99.1%	Passed
Election of Nancy-Ann DeParle	Director		98.7%	Passed
Election of Hugh F. Johnston	Director		98.3%	Passed
Election of Thomas F. Frist III	Director		97.8%	Passed
Election of Robert J. Dennis	Director		96.8%	Passed

2022

Item	Kind	Asked for by	Support	Outcome
The stockholder proposal regarding political spending disclosure as described in the Company’s 2022 proxy statement	Shareholder proposal	John Chevedden	31.7%	Failed
The stockholder proposal regarding lobbying disclosure as described in the Company’s 2022 proxy statement	Shareholder proposal		22.6%	Failed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2022 proxy statement	Company proposal		94.5%	Passed
The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022	Auditor		93.8%	Passed
Election of Andrea B. Smith	Director		99.9%	Passed
Election of Samuel N. Hazen	Director		99.7%	Passed
Election of Meg G. Crofton	Director		99.5%	Passed
Election of Michael W. Michelson	Director		99.3%	Passed
Election of William R. Frist	Director		99.2%	Passed
Election of Hugh F. Johnston	Director		98.5%	Passed
Election of Charles O. Holliday, Jr.	Director		98.3%	Passed
Election of Thomas F. Frist III	Director		97.5%	Passed
Election of Nancy-Ann DeParle	Director		96.7%	Passed
Election of Robert J. Dennis	Director		96%	Passed

2021

Item	Kind	Asked for by	Support	Outcome
The stockholder proposal regarding stockholders’ ability to act by written consent as described in the Company’s 2021 proxy statement	Shareholder proposal	John Chevedden	22.5%	Failed
The stockholder proposal requesting a report on the feasibility of increasing the impact of quality metrics on executive compensation as described in the Company’s 2021 proxy statement	Shareholder proposal		9.8%	Failed
Wayne J. Riley, M.D	Company proposal		98.2%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2021 proxy statement	Company proposal		96.4%	Passed
The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021	Auditor		93.9%	Passed
Election of Meg G. Crofton	Director		99.8%	Passed
Election of Samuel N. Hazen	Director		99.8%	Passed
Election of Michael W. Michelson	Director		99.5%	Passed
Election of William R. Frist	Director		99.5%	Passed
Election of Robert J. Dennis	Director		98.2%	Passed
Election of Thomas F. Frist III	Director		97.9%	Passed
Election of Nancy-Ann DeParle	Director		97.7%	Passed
Election of Charles O. Holliday, Jr.	Director		92.6%	Passed

2020

Item	Kind	Support	Outcome
The stockholder proposal regarding stockholders’ ability to act by written consent as described in the Proxy Statement	Shareholder proposal	19.4%	Failed
The amendment to the Company’s amended and restated certificate of incorporation to allow certain stockholders to request special meetings of stockholders	Company proposal	99.8%	Passed
Wayne J. Riley, M.D	Company proposal	98.9%	Passed
The 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc	Company proposal	95.3%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Proxy Statement	Company proposal	91.1%	Passed
The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2020	Auditor	95.6%	Passed
Election of Michael W. Michelson	Director	99.9%	Passed
Election of Samuel N. Hazen	Director	99.8%	Passed
Election of William R. Frist	Director	99.6%	Passed
Election of Nancy-Ann DeParle	Director	99.5%	Passed
Election of Thomas F. Frist III	Director	99.1%	Passed
Election of Meg G. Crofton	Director	96.8%	Passed
Election of Charles O. Holliday, Jr.	Director	96.5%	Passed
Election of Robert J. Dennis	Director	94.3%	Passed

2019

Item	Kind	Support	Outcome
The amendment to the Company’s amended and restated certificate of incorporation to eliminate supermajority voting requirements	Company proposal	100%	Passed
John W. Rowe, M.D	Company proposal	99%	Passed
Wayne J. Riley, M.D	Company proposal	98.8%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2019 proxy statement	Company proposal	92.1%	Passed
The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019	Auditor	96.3%	Passed
Election of Meg G. Crofton	Director	99.9%	Passed
Election of Samuel N. Hazen	Director	99.9%	Passed
Election of Michael W. Michelson	Director	99.7%	Passed
Election of William R. Frist	Director	99.7%	Passed
Election of Geoffrey G. Meyers	Director	99.6%	Passed
Election of Thomas F. Frist III	Director	99.3%	Passed
Election of Charles O. Holliday, Jr.	Director	99.2%	Passed
Election of Nancy-Ann DeParle	Director	98%	Passed
Election of Robert J. Dennis	Director	67.9%	Passed

2018

Item	Kind	Support	Outcome
John W. Rowe, M.D	Company proposal	99.8%	Passed
Wayne J. Riley, M.D	Company proposal	99.8%	Passed
The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2018 proxy statement	Company proposal	91.1%	Passed
The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2018	Auditor	98.9%	Passed
Election of Michael W. Michelson	Director	99.9%	Passed
Election of William R. Frist	Director	99.9%	Passed
Election of Thomas F. Frist III	Director	99.9%	Passed
Election of Geoffrey G. Meyers	Director	99.8%	Passed
Election of Nancy-Ann DeParle	Director	99.8%	Passed
Election of Charles O. Holliday, Jr.	Director	99.4%	Passed
Election of Ann H. Lamont	Director	98.2%	Passed
Election of R. Milton Johnson	Director	98.2%	Passed
Election of Robert J. Dennis	Director	88.3%	Passed

Proxy statements and vote results

Straight from HCA Healthcare’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.

Year	Filing	Filed
2026	Vote results	2026-04-28
2026	Proxy statement	2026-03-13
2025	Vote results	2025-04-29
2025	Proxy statement	2025-03-14
2024	Vote results	2024-04-30
2024	Proxy statement	2024-03-15
2023	Vote results	2023-04-21
2023	Proxy statement	2023-03-10
2022	Vote results	2022-04-26
2022	Proxy statement	2022-03-11
2021	Vote results	2021-05-04
2021	Proxy statement	2021-03-19
2020	Vote results	2020-05-06
2020	Proxy statement	2020-03-20
2019	Vote results	2019-05-02
2019	Proxy statement	2019-03-15
2018	Vote results	2018-05-02
2018	Proxy statement	2018-03-16

Do you represent HCA Healthcare? Claim this profile to respond to the campaigns listed here.

← All companies